Monsanto (MON) & The Competition Head-To-Head Comparison

Monsanto (NYSE: MON) is one of 27 public companies in the “Agricultural Chemicals” industry, but how does it contrast to its competitors? We will compare Monsanto to similar businesses based on the strength of its valuation, dividends, analyst recommendations, profitability, earnings, institutional ownership and risk.

Valuation and Earnings

This table compares Monsanto and its competitors revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Monsanto $14.52 billion $4.19 billion 25.60
Monsanto Competitors $3.75 billion $757.16 million 14.74

Monsanto has higher revenue and earnings than its competitors. Monsanto is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Risk & Volatility

Monsanto has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500. Comparatively, Monsanto’s competitors have a beta of 0.94, suggesting that their average share price is 6% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations for Monsanto and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Monsanto 0 7 7 0 2.50
Monsanto Competitors 214 818 909 34 2.39

Monsanto presently has a consensus price target of $123.25, suggesting a potential upside of 4.21%. As a group, “Agricultural Chemicals” companies have a potential upside of 0.26%. Given Monsanto’s stronger consensus rating and higher probable upside, research analysts clearly believe Monsanto is more favorable than its competitors.

Dividends

Monsanto pays an annual dividend of $2.16 per share and has a dividend yield of 1.8%. Monsanto pays out 46.8% of its earnings in the form of a dividend. As a group, “Agricultural Chemicals” companies pay a dividend yield of 2.9% and pay out 73.1% of their earnings in the form of a dividend. Monsanto has raised its dividend for 7 consecutive years.

Insider and Institutional Ownership

74.8% of Monsanto shares are owned by institutional investors. Comparatively, 47.5% of shares of all “Agricultural Chemicals” companies are owned by institutional investors. 0.8% of Monsanto shares are owned by insiders. Comparatively, 22.4% of shares of all “Agricultural Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Monsanto and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Monsanto 14.11% 45.26% 11.37%
Monsanto Competitors -398.76% -15.17% -9.33%

Summary

Monsanto beats its competitors on 12 of the 15 factors compared.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity. Through its Seeds and Genomics segment, the Company produces seed brands, including DEKALB, Asgrow, Deltapine, Seminis and De Ruiter, and it develops biotechnology traits that assist farmers in controlling insects and weeds and digital agriculture to assist farmers in decision-making. The Seeds and Genomics segment offers products, such as Germplasm and Biotechnology traits. Through its Agricultural Productivity segment, the Company manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply